• 不 限
  • 期刊论文
  • 硕博论文
  • 会议论文
  • 报 纸
  • 英文论文
  2. 您的位置
  3. 首页
  4. 会议论文
  5. Low prevalence of Hepatitis B virus infection in patients with autoimmune diseases in a Chinese pati

Low prevalence of Hepatitis B virus infection in patients with autoimmune diseases in a Chinese pati

来源 :2014年APASL专题会议暨第四届乙型病毒性肝炎专题会议 | 被引量 : 0次 | 上传用户：G00G01
【摘 要】
：
Background:Hepatitis B is a very common communicable disease in China but the prevalence of hepatitis B virus(HBV) infection in patients with autoimmune diseases is unknown.We retrospectively investig
【作 者】
：
Mingwei Sui Junqi Niu 
【机 构】
：
First hospital of Jilin university
【出 处】
：
2014年APASL专题会议暨第四届乙型病毒性肝炎专题会议
【发表日期】
：
2014年4期
下载到本地 , 更方便阅读
下载此文 赞助VIP
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Background:Hepatitis B is a very common communicable disease in China but the prevalence of hepatitis B virus(HBV) infection in patients with autoimmune diseases is unknown.We retrospectively investigated the prevalence of autoimmune diseases in patients with HBV infection.
其他文献
Interactions between engineered HBV-specific T cells and hepatocellular carcinoma cells in a 3D micr
Background:Hepatocellular carcinoma(HCC) cells often have hepatitis B virus(HBV)-DNA integration and can be targeted by T cells engineered to express HBV-specific T-cell receptors(TCR) as a means of t
会议
Analysis of Chronic Hepatitis B Reverse Transcriptase/S variations generated by Nucleoside Analogues
Background:To study the Characteristics of Reverse Transcriptase(RT) and S gene of Chronic Hepatitis B(CHB) patients generated by Nucleoside Analogues resistance.
会议
Entecavir maleate versus Entecavir in Chinese patients with HBeAg-negative Chronic Hepatitis B:Resul
Background:Entecavir is guanosine analogue with significant activity against HBV.Entecavir maleate is a derivation of entecavir and had been approved by SFDA(State Food and Drug Administration of Chin
会议
The safety and therapeutic efficacy evaluation for UCMSCs transplantation combined with plasma excha
Background:Although previous studies showed that MSCs was a novel and promising treatment method and plasma exchange was also an effective therapy method for liver failure,there were still many proble
会议
Preserved function of circulating invariant natural killer T cells in patients with chronic hepatiti
Background:To date,the role of invariant natural killer T(iNKT) cells in chronic hepatitis B virus(HBV) infection is not fully understood.In previous reports,iNKT cells were identified by indirect met
会议
Identification of BST-2/tetherin-induced hepatitis B virus restriction and hepatocyte-specific BST-2
Background:Hepatitis B virus(HBV) is a major cause of liver disease which belongs to the Hepadnaviridae family of enveloped DNA viruses.BST-2/tetherin is an interferon-inducible antiviral protein that
会议
Impaired Antibody-Dependent Cellular Cytotoxicity Activity of Natural Killer Cells in Chronic HBV in
Background:Natural Killer(NK) cells are a key player in the innate immunity towards virus infection.However,NK phenotype and functional characteristics during chronic HBV infection are largely controv
会议
The Influence of Concomitant Nonalcoholic Fatty Liver Disease on Fibrosis Severity in Patients with
Background:To identify the impact of concomitant nonalcoholic fatty liver disease(NAFLD) on the development of hepatic fibrosis in patients with chronic hepatitis B(CHB).
会议
Detailed Structural Quantification of Hepatic Cirrhosis Progression
Background:Details in change of fibrosis structure in progressive cirrhosis is still unavailable.Taking advantage of qFibrosis tool,the present study aims to address this issue for understanding the p
会议
COMPARATIVE STUDY OF TELBIVUDINE AND PEGYLATED INTERFERON α-2a OPTIMIZATION THERAPY FOR E ANTIGEN-PO
Background:Aim To observe and compare the efficacy of telbivudine and pegalated interferon α-2a optimized therapy for E antigen-positive chronic hepatitis B patients.
会议